Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat"
Antimicrob Agents Chemother
.
2017 Dec 21;62(1):e02034-17.
doi: 10.1128/AAC.02034-17.
Print 2018 Jan.
Authors
Jacqueline M McBride
1
,
Jeremy J Lim
2
,
Tracy Burgess
2
,
Rong Deng
2
,
Michael A Derby
2
,
Mauricio Maia
2
,
Priscilla Horn
2
,
Omer Siddiqui
3
,
Daniel Sheinson
2
,
Haiyin Chen-Harris
2
,
Elizabeth M Newton
2
,
Dimitri Fillos
2
,
Denise Nazzal
2
,
Carrie M Rosenberger
2
,
Maikke B Ohlson
2
,
Rob Lambkin-Williams
4
,
Hosnieh Fathi
4
,
Jeffrey M Harris
2
,
Jorge A Tavel
2
Affiliations
1
Genentech, Inc., South San Francisco, California, USA
[email protected]
.
2
Genentech, Inc., South San Francisco, California, USA.
3
Allakos, Inc., San Carlos, California, USA.
4
hVIVO, London, United Kingdom.
PMID:
29269431
PMCID:
PMC5740363
DOI:
10.1128/AAC.02034-17
No abstract available
MeSH terms
Healthy Volunteers
Humans
Influenza A virus / immunology
Influenza Vaccines / immunology
Influenza, Human / immunology*
Intention to Treat Analysis / methods
Substances
Influenza Vaccines